Cynthia Thaik is a Cardiology physician. OpenAlex indexes 8 publications with 989 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10843 Magnolia Blvd Ste 3
North Hollywood, CA 916013922
Telephone
818-842-1410Provider last certified this registry record 1 Sept 2025.
Industry payments
27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202511 payments
- Novo Nordisk IncProgram year20254 payments
- Boston Scientific CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
92%Angiotensin receptor blocker (ARB)24.7%Olmesartan-Hydrochlorothiazide32%Olmesartan Medoxomil30%Losartan Potassium26%Losartan-Hydrochlorothiazide11%Part D≥33 patientsBeta blocker20.6%Metoprolol Succinate55%Nebivolol Hcl29%Carvedilol16%Part D<11 patients+ 8 more classes in this area
Blood & clotting
5.7%Factor Xa inhibitor5.7%Eliquis77%Xarelto23%Part D<11 patientsMetabolism & gastrointestinal
2.3%Potassium supplement1.2%Potassium Chloride100%Part D<11 patientsSGLT2 inhibitor1%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- BLACK RACE ASSOCIATED WITH WORSE OUTCOMES IN AMBULATORY HEART FAILURE-PRESERVED EJECTION FRACTION PATIENTS
Journal of the American College of Cardiology
2015 - Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
Journal of Clinical Investigation
1998 - Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes.
Journal of Clinical Investigation
1995
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”